Skip to main content
OpenTrials

Clinical trial condition

Postessential Thrombocythemia (Post-ET) Myelofibrosis

Explore clinical trials studying Postessential Thrombocythemia (Post-ET) Myelofibrosis. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Postessential Thrombocythemia (Post-ET) Myelofibrosis trial results

Completed

Momelotinib in Transfusion-Dependent Adults With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)

NCT02515630

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Phoenix, Arizona, United States
  • Los Angeles, California, United States
  • Orange, California, United States
  • Jacksonville, Florida, United States
View all 13 locations
View Trial Details

Related conditions